A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
2/20/2026
BreakingClinical TrialPharmaRegulation
US FDA Will Drop Two-Study Requirement for New Drug Approvals
The US FDA plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, according to a journal article published Feb. 18. Going forward, the agency’s “defaul...
2/20/2026
BreakingCataractCornealDry EyeGlaucomaIOLRevenueSurgical
2025 Ophthalmic Revenue Roundup for Bausch + Lomb and Glaukos
Bausch + Lomb reported Feb. 18 that its 2025 revenue totaled $5.1 billion, a 6 percent increase over $4.8 billion in 2024. The company’s Q4-2025 revenue was $1.4 billion, a 10 percent increase over...
2/20/2026
BreakingRefractiveRegulationSurgical
US FDA Expands Indication for STAAR’s Evo ICL to Patients Up to Age 60
STAAR Surgical announced Feb. 17 that the US FDA had approved an expanded age indication for Evo and Evo+ implantable Collamer lenses (ICLs), extending their use from patients 21 to 45 years old to...
2/20/2026
BreakingClinical TrialPharmaRegulationRetina
Ocular Therapeutix Reports Positive Results for Axpaxli vs. Eylea in Phase III Wet AMD Trial
Ocular Therapeutix reported on Feb. 17 positive topline results in the SOL-1 Phase III superiority trial of Axpaxli vs. Eylea (aflibercept) in wet age-related macular degeneration (AMD). Axpaxli, a...
2/20/2026
BreakingOptometryRegulation
AOA Sounds Alert on Eyebot Vision Kiosks, Calls for Greater Oversight
The American Optometric Association (AOA) is sounding an alert on Eyebot kiosks, where consumers can get 90-second vision tests and doctor-reviewed eyeglass prescriptions. Through a partnership wit...
2/20/2026
BreakingCataractEuropeRegulationSurgical
Eye PCR Gains CE Marking for FixOflex Endocapsular Device
Eye PCR announced Feb. 13 that its FixOflex endocapsular device had gained CE marking under the European Union Medical Device Regulation, clearing the way for a “controlled market introduction.” Th...
2/20/2026
BreakingDealsDiagnosticRetina
Private Equity Firm Sells Maker of RetEval ERG Device to Ametek
The private equity firm DW Healthcare Partners announced Feb. 3 that it had sold LKC Technologies, maker of the RetEval electroretinogram device, to the global electronic instrument manufacturer Am...
2/20/2026
BreakingCornealIndustry
Okyo Pharma Appoints Flavio Mantelli, MD, PhD, as Chief Medical Officer
London’s Okyo Pharma announced Feb. 10 that it had appointed Flavio Mantelli, MD, PhD, as chief medical officer. Mantelli most recently served as chief medical officer of Dompé, where he led the cl...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.